Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Azasetron, (+-)-isomer
2. N-(1-azabicyclo(2.2.2)oct-3-yl)-6-chloro-4-methyl-3-oxo-3,4 -dihydro-2h-1,4-benzoxazine-8-carboxamide Hydrochloride
3. Y 25130
4. Y-25130
1. Nazasetron
2. 123040-69-7
3. Azasetron [inn]
4. 123039-99-6
5. 77hc7urr9z
6. N-(1-azabicyclo[2.2.2]octan-3-yl)-6-chloro-4-methyl-3-oxo-1,4-benzoxazine-8-carboxamide
7. Azasetron (inn)
8. Ncgc00024563-02
9. Y-25130
10. Dsstox_cid_25651
11. Dsstox_rid_81029
12. Dsstox_gsid_45651
13. 2h-1,4-benzoxazine-8-carboxamide, N-1-azabicyclo[2.2.2]oct-3-yl-6-chloro-3,4-dihydro-4-methyl-3-oxo-
14. Cas-123040-69-7
15. Seroton
16. (r)-azasetron
17. 6-chloro-4-methyl-3-oxo-n-(quinuclidin-3-yl)-3,4-dihydro-2h-benzo[b][1,4]oxazine-8-carboxamide
18. Azasetron [mi]
19. Biomol-nt_000105
20. Unii-77hc7urr9z
21. Azasetron [who-dd]
22. Schembl17190
23. Bpbio1_001397
24. Gtpl2285
25. Chembl1598608
26. Dtxsid7045651
27. Schembl13186328
28. Arazasetron, (+/-)-
29. Chebi:91712
30. Tox21 110906
31. Tox21_110906
32. Akos015964402
33. Tox21_110906_1
34. Sb18701
35. (+-)-6-chloro-3,4-dihydro-4-methyl-3-oxo-n-3-quinuclidinyl-2h-1,4-benzoxazine-8-carboxamide
36. (- )-6-chloro-3,4-dihydro-4-methyl-3-oxo-n-3-quinuclidinyl-2h-1,4-benzoxazine-8-carboxamide
37. Ncgc00024563-03
38. Ncgc00024563-04
39. Ncgc00024563-05
40. D07481
41. Ab00640014_08
42. 040a697
43. Q4832285
44. Brd-a44133049-001-01-5
45. Brd-a68360487-003-01-0
46. 6-chloro-3,4-dihydro-4-methyl-3-oxo-n-(3-quinuclidinyl)-2h-1,4-benzoxazine-8-carboxamide
47. 6-chloro-3,4-dihyro-4-methyl-3-oxo-n-(3-quinuclidinyl)-2h-1,4-benzoxazine-8-carboxamide
48. N-(1-azabicyclo[2.2.2]octan-8-yl)-6-chloro-4-methyl-3-oxo-1,4-benzoxazine-8-carboxamide
49. (+/-)-6-chloro-3,4-dihydro-4-methyl-3-oxo-n-3-quinuclidinyl-2h-1,4-benzoxazine-8-carboxamide
50. N-1-azabicyclo[2.2.2]oct-3-yl-6-chloro-4-methyl-3-oxo-3,4-dihydro-2h-1,4-benzoxazine-8-carboxamide
Molecular Weight | 349.8 g/mol |
---|---|
Molecular Formula | C17H20ClN3O3 |
XLogP3 | 1.6 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 2 |
Exact Mass | 349.1193192 g/mol |
Monoisotopic Mass | 349.1193192 g/mol |
Topological Polar Surface Area | 61.9 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 523 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
Serotonin Antagonists
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?